Analysis Of Low Temperature Impact Fracture Data Of Thermoplastic Polymers

Impact fracture toughness of polypropylene (PP) blends, high density polyethylene (HDPE) and rubber toughened polymethylmethacrylate (RTPMMA) has been studied by means of three-point bending falling weight impact testing at different temperatures ranging from -60 degrees C to room temperature using the cleavage fracture toughness, JC parameter [ASTM E1820-99a]. The latter Fracture Mechanics methodology was chosen due to its simplicity [Fasce et al., 2003]. Traces of the impact tests were analyzed using an inverse methodology just proposed by Pettarin et al. (2003). This methodology makes it possible to obtain from a three-point bending instrumented impact test the mechanical response of the material, discarding the dynamic effects associated with the test. The results show that the average JC values calculated with treated and untreated data are similar for a given material, while the standard deviations are larger when the calculations are made with the untreated data. It is clear that the inverse methodology used to correct the data reduces error propagation, giving place to more precise estimations, and therefore more reliable JC values

Uni- and biaxial impact behavior of double-gated nanoclay-reinforced polypropylene injection moldings

Polypopylene/nanoclay three-dimensional parts were produced without intermediate steps by direct injection molding to explore the influence of flow features and nanoclay incorporation in their impact performance. The nanocomposite was obtained by direct compounding of commercial PP with nanoclay masterbatch. The as-molded morphology was analyzed by X-ray and TEM analyses in terms of skin-core structure and nanoclay particle dispersion. The nanoclay particles induced the reduction of b-form spherulites, a known toughener. The impact behavior was assessed in tensile and biaxial modes. The PP nanocomposite molding toughness was practically unaffected by the processing melt temperature and flow rate. Conversely the nanoclay presence is influent in the impact performance. Under biaxial stress impact, the regions close to weld lines are tougher than the bulk and the fracture develops with main crack paths along the flow direction and the weld line. Cracking along the weld line results from less macromolecular interpenetration and chain entanglement, and unfavorable nanoparticle orientation. It seems that a failure mechanism which involves nanoclay delamination and multiple matrix crazing explains the toughening of PP in the directions where the nanoparticle orientation with respect to loading is adequate.Contract grant sponsors: CONICET, ANPCyT from Argentina, MINCyT (Argentina) - FCT (Portugal), Universities Nacional de Mar del Plata and Minho

Surface property effects of compounding a nanoclay masterbatch in PP injection moulding

Indicado para o prémio de melhor artigo mais inovador.The interest on the use of nanofillers in injection mouldings has been going on for more than a decade but a real breakthrough has not been achieved yet, especially in that mechanical properties are concerned. The nucleating effect of nanoclays in semicrystalline polymers suggests that surface effects may result interesting especially during processing. This paper includes some information on the surface properties of an injection moulding grade of polypropylene mixed with a commercial masterbatch of PP and 50% of organoclay. They were moulded as plates for testing in a prototype device for determining the coefficient of friction in as-moulding conditions. The surface was also characterised by depth sensing indentation tests. The through thickness microstructures of the mouldings were assessed by optical microscopy and differential scanning calorimetry, while surface morphology was assessed by X-ray diffraction. It was observed that independently of MB content, its addition caused a slight increase in elastic modulus and hardness in the skin layer.The friction properties directly associable to the product performance showed a slight improvement in terms of the dynamic friction coefficient. Conversely the static friction coefficient that is relevant in processing was no affected by the presence of the nanoclay

Synergistic effects of nanoclay and SGF on tribological and dynamic properties of polypropylene composites

In recent year’s polymer/layered silicate (PLS) nanocomposites have attracted great interest, both in industry and in academia, because they often exhibit remarkable improvement in materials properties when compared with virgin polymer or conventional micro and macrocomposites. These improvements can include high moduli, increased strength and heat resistance, decreased gas permeability and flammability, and increased biodegradability of biodegradable polymers. However these properties are strongly influenced by how the clay is dispersed in the polymer. In this study the synergistic effects in PP+short glass fiber+nanoclay systems in the tribogical and dynamic properties in injection mouldings were analysed. The materials used were a Polypropylene Homopolymer, Nanoclay (montmorillonite layer silicate) for Polyolefin Nanocomposites in percentages of 2%, 6% and 10% and a Polypropylene Homopolymer with content of 10% and 30% of glass fiber reinforced. The various materials systems were characterized in terms of dynamic properties and tribological properties. Several tests were conducted which includes the measurements of coefficient of friction in conditions similar to the ejection phase in injection moulding process. The microstructure of the mouldings was characterized by DSC. Polymer properties are determined by the incorporation of nanoclays, SGF and by processing. Moreover influencing the microstructure of the mouldings and a synergistic effect of the nano and micro reinforcements are also observed

An instrument to measure psychosocial determinants of health care professionals' vaccination behavior: Validation of the Pro-VC-Be questionnaire

Objectives: The lack of validated instruments assessing vaccine hesitancy/confidence among health care professionals (HCPs) for themselves, and their patients led us to develop and validate the Pro-VC-Be instrument to measure vaccine confidence and other psychosocial determinants of HCPs' vaccination behavior among diverse HCPs in different countries.Methods: Cross-sectional survey in October-November 2020 among 1,249 GPs in France, 432 GPs in French-speaking parts of Belgium, and 1,055 nurses in Quebec (Canada), all participating in general population immunization. Exploratory and confirmatory factor analyses evaluated the instrument's construct validity. We used HCPs' self-reported vaccine recommendations to patients, general immunization activity, self-vaccination, and future COVID-19 vaccine acceptance to test criterion validity.Results: The final results indicated a 6-factor structure with good fit: vaccine confidence (combining complacency, perceived vaccine risks, perceived benefit-risk balance, perceived collective responsibility), trust in authorities, perceived constraints, proactive efficacy (combining commitment to vaccination and self-efficacy), reluctant trust, and openness to patients. The instrument showed good convergent and criterion validity and adequate discriminant validity.Conclusions: This study found that the Pro-VC-Be is a valid instrument for measuring psychosocial determinants of HCPs' vaccination behaviors in different settings. Its validation is currently underway in Europe among various HCPs in different languages.</p

Epidemiological trends in nosocomial candidemia in intensive care

BACKGROUND: Infection represents a frequent complication among patients in Intensive Care Units (ICUs) and mortality is high. In particular, the incidence of fungal infections, especially due to Candida spp., has been increasing during the last years. METHODS: In a retrospective study we studied the etiology of candidemia in critically ill patients over a five-year period (1999–2003) in the ICU of the San Martino University Hospital in Genoa, Italy. RESULTS: In total, 182 episodes of candidaemia were identified, with an average incidence of 2.22 episodes/10 000 patient-days/year (range 1.25–3.06 episodes). Incidence of candidemia increased during the study period from 1.25 in 1999 to 3.06/10 000 patient-days/year in 2003. Overall, 40% of the fungemia episodes (74/182) were due to C.albicans, followed by C. parapsilosis(23%), C.glabrata (15%), C.tropicalis (9%) and other species (13%). Candidemia due to non-albicans species increased and this was apparently correlated with an increasing use of azoles for prophylaxis or empirical treatment. CONCLUSION: The study demonstrates a shift in the species of Candida causing fungemia in a medical and surgical ICU population during a 5 year period. The knowledge of the local epidemiological trends in Candida species isolated in blood cultures is important to guide therapeutic choices

One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy

Background: Cataract surgery is the most common operation performed worldwide. A fixed topical corticosteroid-antibiotic combination is usually prescribed in clinical practice for 2 or more weeks to treat post surgical inflammation and prevent infection. However, this protracted schedule may increase the incidence of corticosteroid-related adverse events and notably promote antibiotic resistance. Methods: This International, multicentre, randomized, blinded-assessor, parallel-group clinical study evaluated the non-inferiority of 1-week levofloxacin/dexamethasone eye drops, followed by 1-week dexamethasone alone, vs. 2-week gold-standard tobramycin/dexamethasone (one drop QID for all schedules) to prevent and treat ocular inflammation and prevent infection after uncomplicated cataract surgery. Non-inferiority was defined as the lower limit of the 95% confidence interval (CI) around a treatment difference >\u201310%. The study randomized 808 patients enrolled in 53 centres (Italy, Germany, Spain and Russia). The primary endpoint was the proportion of patients without anterior chamber inflammation on day 15 defined as the end of treatment. Endophthalmitis was the key secondary endpoint. This study is registered with EudraCT code: 2018-000286-36. Results: After the end of treatment, 95.2% of the patients in the test arm vs. 94.9% of the control arm had no signs of inflammation in the anterior chamber (difference between proportions of patients = 0.028; 95% CI: 120.0275/0.0331). No case of endophthalmitis was reported. No statistically significant difference was evident in any of the other secondary endpoints. Both treatments were well tolerated. Conclusions: Non-inferiority of the new short pharmacological strategy was proven. One week of levofloxacin/dexamethasone prevents infection, ensures complete control of inflammation in almost all patients and may contain antibiotic resistance

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

BACKGROUND: The development of vaccines to control the COVID-19 pandemic progression is a worldwide priority. CoronaVac® is an inactivated SARS-CoV-2 vaccine approved for emergency use with robust efficacy and immunogenicity data reported in trials in China, Brazil, Indonesia, Turkey, and Chile. METHODS: This study is a randomized, multicenter, and controlled phase 3 trial in healthy Chilean adults aged ≥18 years. Volunteers received two doses of CoronaVac® separated by two (0-14 schedule) or four weeks (0-28 schedule). 2,302 volunteers were enrolled, 440 were part of the immunogenicity arm, and blood samples were obtained at different times. Samples from a single center are reported. Humoral immune responses were evaluated by measuring the neutralizing capacities of circulating antibodies. Cellular immune responses were assessed by ELISPOT and flow cytometry. Correlation matrixes were performed to evaluate correlations in the data measured. RESULTS: Both schedules exhibited robust neutralizing capacities with the response induced by the 0-28 schedule being better. No differences were found in the concentration of antibodies against the virus and different variants of concern between schedules. Stimulation of PBMCs with MPs induced the secretion of IFN-g and the expression of activation induced markers for both schedules. Correlation matrixes showed strong correlations between neutralizing antibodies and IFN-g secretion. CONCLUSIONS: Immunization with CoronaVac® in Chilean adults promotes robust cellular and humoral immune responses. The 0-28 schedule induced a stronger humoral immune response than the 0-14 schedule. FUNDING: Ministry of Health, Government of Chile, Confederation of Production and Commerce & Millennium Institute on Immunology and Immunotherapy, Chile. CLINICAL TRIAL NUMBER: NCT04651790

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series

Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. Methods In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. Findings We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 years (2·0–10·0) in upper middle-income countries, and 7·0 years (3·6–16·8) in high-income countries. Interpretation This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries